Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.073 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |